Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Moderate Aplastic Anemia, PRCA, and DBA
NCT00229619Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 2005
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in aplastic anemia, pure red cell aplasia (PRCA), Diamond-Blackfan anemia (DBA), sponsored by National Heart, Lung, and Blood Institute. Started Sep 2005; status: completed.
02
Drugs
rituximab
03
Conditions
aplastic anemiapure red cell aplasia (PRCA)Diamond-Blackfan anemia (DBA)
Beyond the preview
Go deeper on NCT00229619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229619.